Aktuellt
SENASTE
BB Biotech has released its interim report for Q1/21. BB Biotech is a dedicated biotech investment fund and the fund has done well in challenging markets in the first quarter of 2021 when looking at its share price performance. The fund has used the sector re-evaluation in Q1 to make new portfolio investments, we will update our NAV accordingly. Here we post some of the comments from the company's newly released report.
LÄS MER
